%D9%81%D8%B1%D9%8A%D8%AF_%D9%85%D8%B1%D8%A7%D8%AFF%C9%99rid_Murad%D9%81%D8%B1%DB%8C%D8%AF_%D9%85%D8%B1%D8%A7%D8%AF%D0%A4%D0%B5%D1%80%D1%8B%D0%B4_%D0%9C%D1%83%D1%80%D0%B0%D0%B4%D0%A4%D0%B5%D1%80%D0%B8%D0%B4_%D0%9C%D1%83%D1%80%D0%B0%D0%B4%E0%A6%AB%E0%A6%B0%E0%A6%BF%E0%A6%A6_%E0%A6%AE%E0%A7%81%E0%A6%B0%E0%A6%BE%E0%A6%A6Ferid_MuradCategory:Ferid_MuradFerid_MuradFerid_MuradFerid_MuradFerid_MuradFerid_MuradFerid_Murad%D9%81%D8%B1%DB%8C%D8%AF_%D9%85%D8%B1%D8%A7%D8%AFFerid_MuradFerid_MuradFerid_Murad%D7%A4%D7%A8%D7%99%D7%93_%D7%9E%D7%95%D7%A8%D7%93Ferid_MuradFerid_Murad%D5%96%D5%A5%D6%80%D5%AB%D5%A4_%D5%84%D5%B8%D6%82%D6%80%D5%A1%D5%A4Ferid_MuradFerid_MuradFerid_Murad%E3%83%95%E3%82%A7%E3%83%AA%E3%83%89%E3%83%BB%E3%83%A0%E3%83%A9%E3%83%89%D0%A4%D0%B5%D1%80%D0%B8%D0%B4_%D0%9C%D1%83%D1%80%D0%B0%D0%B4%ED%8E%98%EB%A6%AC%EB%93%9C_%EB%AE%A4%EB%9D%BC%EB%93%9C%D0%A4%D0%B5%D1%80%D0%B8%D0%B4_%D0%9C%D1%83%D1%80%D0%B0%D0%B4Ferid_MuradFerid_MuradFerid_MuradFerid_MuradFerid_MuradFerid_Murad%D9%81%DB%8C%D8%B1%D8%AF_%D9%85%D9%88%D8%B1%D8%A7%D8%AFFerid_Murad%D0%9C%D1%83%D1%80%D0%B0%D0%B4,_%D0%A4%D0%B5%D1%80%D0%B8%D0%B4Ferid_MuradFerid_Murad
about
Cyclic guanosine monophosphate as a mediator of vasodilationSodium nitroprusside-induced protein phosphorylation in intact rat aorta is mimicked by 8-bromo cyclic GMPRNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclasePyridopyrimidine derivatives as inhibitors of cyclic nucleotide synthesis: Application for treatment of diarrhea.Protein tyrosine nitration in the mitochondria from diabetic mouse heart. Implications to dysfunctional mitochondria in diabetes.Mass spectrometry-based relative quantification of human neutrophil peptides 1, 2, and 3 from biological samples.Mapping sites of tyrosine nitration by matrix-assisted laser desorption/ionization mass spectrometry.Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation.Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein HBx requires MTA1 coregulator.Helminth regulation of host IL-4Ralpha/Stat6 signaling: mechanism underlying NOS-2 inhibition by Trichinella spiralisCCTeta, a novel soluble guanylyl cyclase-interacting protein.Hydrogen peroxide alters splicing of soluble guanylyl cyclase and selectively modulates expression of splicing regulators in human cancer cells.Cyclic GMP-independent mechanisms contribute to the inhibition of platelet adhesion by nitric oxide donor: a role for alpha-actinin nitration.Vasodilatory effects of cinnamaldehyde and its mechanism of action in the rat aorta.Protein nitration in cardiovascular diseases.Nitric oxide (NO)--biogeneration, regulation, and relevance to human diseases.Histone H1.2 is a substrate for denitrase, an activity that reduces nitrotyrosine immunoreactivity in proteins.The nature of heme/iron-induced protein tyrosine nitration.A constitutively activated mutant of human soluble guanylyl cyclase (sGC): implication for the mechanism of sGC activation.Nitric oxide-cyclic GMP signaling in stem cell differentiationDifferential Effects of Cold Atmospheric Plasma in the Treatment of Malignant GliomaRegulation of nitric oxide and soluble guanylyl cyclase.Targeting different types of human meningioma and glioma cells using a novel adenoviral vector expressing GFP-TRAIL fusion protein from hTERT promoter.CCAAT-binding factor regulates expression of the beta1 subunit of soluble guanylyl cyclase gene in the BE2 human neuroblastoma cell line.Anti-Inflammatory Effect of 1,3,5,7-Tetrahydroxy-8-isoprenylxanthone Isolated from Twigs of Garcinia esculenta on Stimulated MacrophageDynamic interplay between nitration and phosphorylation of tubulin cofactor B in the control of microtubule dynamics.NO-cGMP signaling in development and stem cells.Proteomic modification by nitric oxide.NO-cGMP signaling and regenerative medicine involving stem cells.Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development.Alpha1 soluble guanylyl cyclase (sGC) splice forms as potential regulators of human sGC activityRutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathwaysStabilizing the cold plasma-stimulated medium by regulating medium's composition.Vascular system: role of nitric oxide in cardiovascular diseases.Nitric oxide and cyclic guanosine monophosphate signaling in the eye.A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinases.Discovery of the nitric oxide signaling pathway and targets for drug development.Nitric oxide signaling in vascular biology.Nitric oxide: a guardian for vascular grafts?NOS-2 signaling and cancer therapy.
P50
Q24623087-4B95AC61-1B20-4451-88D0-2D47C7F3F8DFQ24629210-E4E60014-CF0C-4B64-A1DD-5518625A043CQ27001569-3EFDE963-400A-4132-BD3A-D147B083CB19Q30440623-52CC7F05-1474-44E9-90BA-F0AD04A24BEDQ30951426-9267F23B-0CF8-477C-85A2-1B2C875B0B3EQ33226109-F7335DF4-5FCB-40FD-8B4A-089E09610F27Q33227313-E2D7B136-C2EB-4590-85A0-A25A6F7F38A0Q33727318-E1C0398A-477D-4D66-9BD7-60F793E8A477Q33747940-BE3C43FF-B031-4FE6-8772-5A17F1EBBE83Q33932534-86B07094-071C-4ACC-B2E3-DCF1D67A5DDAQ34345769-61BA79E0-C3DC-4C36-8071-1735758944A9Q34387675-B243EC54-9D8B-4499-9EE4-ADE30046748AQ34480130-34032985-B057-4670-98F9-BC11479D4967Q34987185-0E1B64C9-7AB5-44F6-8EEA-FAEC8B442513Q34995532-5EF1B463-8A14-46C5-9AA5-EDB18711ADEFQ35011386-3F327220-846C-4A9E-92A2-3B43F147E65DQ35021735-CCFFA6EA-0B18-4BC8-BDB0-87A5E2309169Q35021938-A890FF69-F6BA-489E-8D8D-1E59EC9D4AD9Q35234315-052BB4CF-5CE3-4471-A977-E3E08C2AE6C1Q35596709-79A7FB17-D0F1-4543-A9CF-E795D070C115Q35666016-F100AE79-6E31-4266-B80B-A13C39CA07BEQ35704136-FEF4E05D-239B-4534-B378-D57F14FC06FFQ35768756-5043DB04-753D-4B43-9706-6C5AAA486B77Q36161217-EA582E8D-E2E3-4958-A3B9-5524372BD3A3Q36204549-101E6DC3-B320-4E4D-BFAA-B65A3868FAC2Q36288660-36A2A925-4CFE-475A-86CB-E781A8735113Q36342941-D5643B70-7380-4F7E-8E3A-B4782AF1FCD0Q36557787-4CDBDAE3-C3F9-462D-819C-CF1D89DC6F4CQ36624547-55B0C436-5936-4DAE-B54A-389B1347255FQ36648534-A14E9D0E-A5AE-4193-A05B-4B22D2C680A5Q36678534-EC1B8CE8-46C0-49E8-AE6D-83636F75F3A6Q36765138-86445450-F27D-4221-B8BA-532E174CC872Q36898379-51DF66C3-33F5-47E7-95D3-9E05E2ECDCE7Q37133914-B208FDA0-2DF5-4084-8C3F-836AC59DDF88Q37149907-CC34AAA2-4BDD-4DF4-B159-4EB9580D5705Q37352747-AEFCC864-525A-46BC-86FE-AFA3A838B48CQ37409901-8BB491D7-92AF-4F11-8089-55EC01BA7144Q37735480-F7BDD36A-90DE-47E6-8FAD-7EBAAE633F1DQ37887771-624E66FD-75A5-4682-9760-20799444DBC9Q38020147-E086F595-BD18-43AB-89A0-1348981E9B6C
P50
subject
description
American physician and pharmacologist
@en
Amerikaans arts
@nl
US-amerikanischer Wissenschaftler und Nobelpreisträger für Medizin
@de
biologiste et pharmacologiste américain
@fr
dokter asal Amerika Serikat
@id
farmakolog amerykański, noblista
@pl
medico e farmacologo statunitense
@it
name
Ferid Murad
@ast
Ferid Murad
@ca
Ferid Murad
@cs
Ferid Murad
@cy
Ferid Murad
@da
Ferid Murad
@de
Ferid Murad
@en
Ferid Murad
@es
Ferid Murad
@et
Ferid Murad
@eu
type
label
Ferid Murad
@ast
Ferid Murad
@ca
Ferid Murad
@cs
Ferid Murad
@cy
Ferid Murad
@da
Ferid Murad
@de
Ferid Murad
@en
Ferid Murad
@es
Ferid Murad
@et
Ferid Murad
@eu
altLabel
Ferid Murad
@sq
Murad
@sv
Мурад Ф.
@ru
Мурад Ферид
@ru
Ферид Мурад
@ru
费瑞德·穆拉德
@zh
prefLabel
Ferid Murad
@ast
Ferid Murad
@ca
Ferid Murad
@cs
Ferid Murad
@cy
Ferid Murad
@da
Ferid Murad
@de
Ferid Murad
@en
Ferid Murad
@es
Ferid Murad
@et
Ferid Murad
@eu